Episode 87: Attacking Bladder Cancer From All Sides

Published on: 

Arthur Kuan, CEO of CG Oncology, talks about the present and future of bladder cancer therapies, and how he’s committed to making a difference.

Arthur Kuan, CEO of CG Oncology, discusses bladder cancer therapies and how his company is contributing to the fight.

Related Content:

Editorial Podcasts
Avoiding Commercialization Pitfalls for CGTs
Ethical AI Practices
Drug Pricing Challenges and Navigating the IRA